The Utility of CAPTEM in Chemo-Resistant Neuroendocrine Tumors
Published: | Updated:
Robert L. Fine, MD, from Columbia University, comments on the utility of CAPTEM in chemotherapy-resistant neuroendocrine tumors.
Robert L. Fine, MD
Articles by Robert L. Fine, MD
Reducing the Risk of Relapse in Patients With Pancreatic Cancer
Published: | Updated:
Robert L. Fine, MD, from Columbia University, discusses reducing the risk of relapse in patients with pancreatic cancer.
Latest Updated Articles
The Utility of CAPTEM in Chemo-Resistant Neuroendocrine TumorsPublished: April 24th 2014 | Updated: April 17th 2020
Reducing the Risk of Relapse in Patients With Pancreatic CancerPublished: February 24th 2014 | Updated: April 18th 2020